TY  - JOUR
AU  - Diaz-Tocados, Juan M
AU  - Rodriguez-Ortiz, Maria E
AU  - Almaden, Yolanda
AU  - Pineda, Carmen
AU  - Martinez-Moreno, Julio M
AU  - Herencia, Carmen
AU  - Vergara, Noemi
AU  - Pendon-Ruiz de Mier, M Victoria
AU  - Santamaría, Rafael
AU  - Rodelo-Haad, Cristian
AU  - Casado-Diaz, Antonio
AU  - Lorenzo, Victor
AU  - Carvalho, Catarina
AU  - Frazão, João M
AU  - Felsenfeld, Arnold J
AU  - Richards, William G
AU  - Aguilera-Tejero, Escolástico
AU  - Rodriguez, Mariano
AU  - Lopez, Ignacio
AU  - Muñoz-Castañeda, Juan R
PY  - 2018
DO  - 10.1016/j.kint.2018.12.015
UR  - http://hdl.handle.net/10668/13716
T2  - Kidney international
AB  - Calcimimetics decrease parathyroid hormone (PTH) secretion in patients with secondary hyperparathyroidism. The decrease in PTH should cause a reduction in bone turnover; however, the direct effect of calcimimetics on bone cells, which express the...
LA  - en
PB  - Elsevier
KW  - CaSR
KW  - Bone
KW  - Calcimimetic
KW  - Chronic kidney disease
KW  - Mineral metabolism
KW  - Parathyroid hormone
KW  - Animals
KW  - Biphenyl compounds
KW  - Bone remodeling
KW  - Calcimimetic agents
KW  - Disease models, animal
KW  - Humans
KW  - Hyperparathyroidism, secondary
KW  - Kidney failure, chronic
KW  - Male
KW  - Osteoblasts
KW  - Parathyroid hormone
KW  - Phenethylamines
KW  - Rats
KW  - Rats, Wistar
KW  - Receptors, calcium-sensing
TI  - Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration.
TY  - research article
VL  - 95
ER  -